2014 論文・総説（英語） Publications（International）
| 1 |
Liu G, Hitomi H, Rahman A, Nakano D, Mori H, Masaki T, Ma H, Iwamoto T, Kobori H, Nishiyama A Hypertens Res. 2014 Jan;37(1):13-18. |
 |
| 2 |
Sofue T, Inui M, Hara T, Moriwaki K, Kushida Y, Kakehi Y, Nishiyama A, Kohno M. Transplantation. 2014 Jan 15;97(1):104-110. |
|
| 3 |
Nishioka S, Nakano D, Kitada K, Sofue T, Ohsaki H, Moriwaki K, Hara T, Ohmori K, Kohno M, Nishiyama A. Kidney Int. 2014 Apr;85(4):871-879. |
|
| 4 | Podocyte injury enhances filtration of liver-derived angiotensinogen and renal angiotensin II generation. Matsusaka T, Niimura F, Pastan I, Shintani A, Nishiyama A, Ichikawa I. Kidney Int. 2014 May;85(5):1068-1077. |
|
| 5 | Angiotensin II dose-dependently stimulates human renal proximal tubule transport via NO/cGMP pathway. Running title: Ang II effects on proximal tubules. Shirai A, Yamazaki O, Horita S, Nakamura M, Satoh N, Yamada H, Suzuki M, Kudo A, Kawakami H, Hofmann F, Nishiyama A, Kume H, Enomoto Y, Homma Y, SekiG. J Am Soc Nephrol. 2014 Jul;25(7):1523-1532. |
|
| 6 | Predictive significance of kidney myeloid related protein 8 expression
in patients with obesity- or type 2 diabetes-associated kidney diseases. Kuwabara T, Mori K, Kasahara M, Yokoi H, Imamaki H, Ishii A, Koga K, Sugawara A, Yasuno S, Ueshima K, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Nakao K, Mukoyama M. PLoS ONE. 2014 Feb 18;9(2):e88942. |
|
| 7 | Chymase activities and survival in endotoxin-induced human chymase transgenic
mice. Rafiq K, Fan YY, Sherajee SJ, Takahashi Y, Matsuura J, Hase N, Mori H, Nakano D, Kobara H, Hitomi H, Masaki T, Urata H, Nishiyama A Int J Med Sci.2014 Jan 11;11(3):222-225. |
|
| 8 | Is antioxidant therapy effective for advanced hypertension and renal injury? Rafiq K, Nishiyama A. J Hypertens. 2014 Mar;32(3):475-476. |
|
| 9 | Liver-specific angiotensinogen suppression: an old yet novel target for
blood pressure control through RAS inhibition? Kitada K, Kobori H, Nishiyama A. Hypertens Res. 2014 May;37(5):393-394. |
|
| 10 | Serum soluble (pro)renin receptor levels in patients with essential hypertension. Morimoto S, Ando T, Niiyama M, Seki Y, Yoshida N, Watanabe D, Kawakami-Mori F, Kobori H, Nishiyama A, Ichihara A. Hypertens Res. 2014 Jul;37(7):642-648. |
|
| 11 | Efficacy and safety of febuxostat in the treatment of hyperuricemia in
stable kidney transplant recipients. Sofue T, Inui M, Hara T, Nishijima Y, Moriwaki K, Hayashida Y, Ueda N, Nishiyama A, Kakehi Y, Kohno M Drug Des Devel Ther.2014 Feb 17;8:245-253. |
|
| 12 | Deletion of the angiotensin II type 1 receptor-associated protein enhances
renal sodium reabsorption and exacerbates angiotensin II-mediated hypertension. Ohsawa M, Tamura K, Wakui H, Maeda A, Dejima T, Kanaoka T, Azushima K, Uneda K, Tsurumi-Ikeya Y, Kobayashi R, Matsuda M, Uchida S, Toya Y, Kobori H, Nishiyama A, Yamashita A, Ishikawa Y, Umemura S. Kidney Int. 2014 Sep;86(3):570-581. |
|
| 13 | Effect of the renin inhibitor aliskiren against retinal ischemia-reperfusion
injury. Tenkumo K, HirookaK, Sherajee SJ, Nakamura T, Itano T, Nitta E, Fujita T, Nishiyama A, Shiraga F. Exp Eye Res. 2014 May;122:110-118. |
|
| 14 | Calcitriol supplementation improves endothelium-dependent vasodilation
in rat hypertensive renal injury Takenaka T, Inoue T, Ohno Y, Miyazaki T, Nishiyama A, Ishii N, Suzuki H. Kidney Blood Press Res. 2014 Apr 30;39(1):17-27. |
|
| 15 |
Detailed Localization of Augmented Angiotensinogen mRNA and Protein in
Proximal Tubule Segments of Diabetic Kidneys in Rats and Humans. Kamiyama M, Garner M K, Farragut K M, Sofue T, Hara T, Morikawa T, Konishi Y, Imanishi M, Nishiyama A, Kobori H. Int J Biol Sci. 2014 May 3;10(5):530-542. |
|
| 16 | Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent
pathway in proximal tubules in the early stage of diabetic nephropathy Kitada K, Nakano D, Ohsaki H, Hitomi H, Minamino T, Yatabe J, Felder RA, Mori H, Masaki T, Kobori H, Nishiyama A. J Diabetes Complications. 2014 Sep-Oct;28(5):604-611. |
|
| 17 | Regression of glomerular and tubulointerstitial injuries by dietary salt
reduction with combination therapy of angiotensin II receptor blocker and
calcium channel blocker in Dahl salt-sensitive rats. Rafiq K, Nishiyama A, Konishi Y, Morikawa T, Kitabayashi C, Kohno M, Masaki T, Mori H, Kobori H, Imanishi M. PLoS One. 2014 Sep 18;9(9):e107853 |
|
| 18 | Circadian rhythm of plasma and urinary angiotensinogen in healthy volunteers
and in patients with chronic kidney disease. Nishijima Y, Kobori H, Kaifu K, Mizushige T, Hara T, Nishiyama A, Kohno M. J Renin Angiotensin Aldosterone Syst. 2014 Dec;15(4):505-508. |
|
| 19 | Different mechanisms of acute versus long-term antihypertensive effects of soluble epoxide hydrolase inhibition: studies in Cyp1a1-Ren-2 transgenic rats. Sporkov・ A, J・chov・ S, Huskov・ Z, Kopkan L, Nishiyama A, Hwang SH, H ammock BD, Imig JD, Kompanowska-Jezierska E, Sadowski J, Kramer HJ, Cervenka L. Clin Exp Pharmacol Physiol. 2014 Dec;41(12):1003-1013. |
|
| 20 | Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Petr Kujal, Vera Certikova Chabova, Petra Skaroupkova, Zuzana Huskova, Zdena Vernerova, Herbert J. Kramer, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Kento Kitada, Akira Nishiyama, Sung H. Hwang, Bruce D. Hammock, John D. Imig, Ludek Cervenka CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY 41(3) 227 - 237 |
|
| 21 | Angiotensin receptor blockade improves antioxidant activity by increasing nrf2 activation during a glucose challenge. Max Thorwald, Ruben Rodriguez, Andrew Lee, Bridget Martinez, Daisuke Nakano, Akira Nishiyama, Rudy Ortiz. FASEB JOURNAL 2014 Apr. 28(1). |
|
| 22 | High fat diet decreases fractional sodium excretion and increases systolic blood pressure via angiotensin II-mediated increase in epithelial sodium channel abundance. Jacqueline Minas, Daisuke Nakano, Mouhamed Awayda, Akira Nishiyama, Rudy Ortiz FASEB JOURNAL 2014 Apr. 28(1). |
|
| 23 | Angiotensin II and mineralocorticoid receptor antagonism decrease cardiac nitrotyrosine content and recover glutathione peroxidase activity in Angiotensin II-infused rats. Jacqueline Minas, Max Thorwald, Debra Conte, Jose-Pablo Vazguez-Medina, Akira Nishiyama, Rudy Ortiz. FASEB JOURNAL 2014 Apr. 28(1). |
|
| 24 | Exogenous thyroxine (T4) attenuates glucose intolerance and insulin resistance in obese Otsuka Long-Evans Tokushima Fatty rats. Guillermo Vazquez-Anaya, Bridget Martinez, Daisuke Nakano, Akira Nishiyama, Rudy Ortiz. FASEB JOURNAL 2014 Apr. 28(1). |
|
| 25 | Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Petr Kujal, Vera ?ertikova Chabova, Petra ?karoupkova, Zuzana Huskova, Zdena Vernerova, Herbert J Kramer, Agnieszka Walkowska, Elzbieta Kompanowska-Jezierska, Janusz Sadowski, Kento Kitada, Akira Nishiyama, Sung H Hwang, Bruce D Hammock, John D Imig, Ludek ?ervenka. Clinical and experimental pharmacology & physiology 41(3) 227 - 37 2014 Jun. |
|
| 26 | Multiphoton imaging of septic kidney. Daisuke Nakano, Akira Nishiyama. JOURNAL OF PHARMACOLOGICAL SCIENCES 124 125P - 125P 2014. |
|
| 27 | The role of N-type calcium channel in renal podocytes. Ya Liu, Daisuke Nakano, Yuki Shibayama, Akira Nishiyama. JOURNAL OF PHARMACOLOGICAL SCIENCES 124 126P - 126P 2014. |
|
| 28 | Effects of high salt diet on daily BP and RSNA, and circadian rhythm in freely moving conscious rats. Yoshihide Fujisawa, Daisuke Nakano, Hirofumi Hitomi, Hiroyuki Kobori, Akira Nishiyama. JOURNAL OF PHARMACOLOGICAL SCIENCES 124 225P - 225P 2014. |
|
| 29 | Spectrum correction considering light source fluctuation for non-invasive blood glucose sensing. Satoru Suzuki, Akane Ishida, Pradeep K.W. Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. Progress in Biomedical Optics and Imaging - Proceedings of SPIE 8936 2014. |
|
| 30 | Wide-field spectroscopic imaging of biological-substance distributions on entire faces by measuring middle infrared lights emitted from human bodies itself. Yo Suzuki, Wei Qi, Masaru Fujiwara, Hiroyuki Hiramatsu, Satoru Suzuki, Pradeep Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. Progress in Biomedical Optics and Imaging - Proceedings of SPIE 8951 2014. |
|
| 31 | Quantitative measurement of biological substances in daily-life environment with the little-finger-size one-shot spectroscopic tomography. Akane Ishida, Shun Sato, Sho Nakada, Satoru Suzuki, P. K.W. Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. Progress in Biomedical Optics and Imaging - Proceedings of SPIE 8951 2014. |
|
| 32 | Measurement of the mid-infrared fourier spectroscopic imaging of whole human face by portable apparatus (Size: 50?50mm, Weight: 200g). Wei Qi, Yo Suzuki, Masaru Fujiwara, Tsubasa Saito, Satoru Suzuki, Pradeep Kumara Abeygunawardhana, Kenji Wada, Akira Nishiyama, Ichiro Ishimaru. Progress in Biomedical Optics and Imaging - Proceedings of SPIE 9268 2014. |
|
| 33 | What is difference in SGLT2 inhibitors? -A comparison on pharmacokinetic properties. Akira Nishiyama, Koji Murao. Japanese Pharmacology and Therapeutics 43 241 - 247 2014. |
|
| 34 | Inhibitation of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats. Kujal P, Certikova Chabova V, Skaroupkova P, Huskova Z, Vernerova Z, Kramer HJ, Walkowska A, Kompanowska-Jezierska E, Sadowski J, Kitada K, Nishiyama A, Hwang SH, Hammock BD, Imig JD, Cervenka L. Clin Exp Pharmacol Physiol. 2014; 41(3): 227-237. |
|